Document
IPR2020-01053, No. 2136 Exhibit - McElroy et al, Pharmacologic Agents for the Treatment of AcuteBipolar Mania (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2136 Exhibit - McElroy et al, Pharmacologic Agents for the Treatment of AcuteBipolar Mania (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2067 Exhibit - DiMasi et al The price of innovation new estimates of drugdevelopment costs (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2067 Exhibit - DiMasi et al The price of innovation new estimates of drugdevelopment costs (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2070 Exhibit - Latuda Product Monograph (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2070 Exhibit - Latuda Product Monograph (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2056 Exhibit - Stimmel at al, Ziprasidone An Atypical Antipsychotic Drug for theTreatment of Schizophrenia (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2056 Exhibit - Stimmel at al, Ziprasidone An Atypical Antipsychotic Drug for theTreatment of Schizophrenia (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2091 Exhibit - Comparison of Atypical Antipsychotics (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2091 Exhibit - Comparison of Atypical Antipsychotics (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2047 Exhibit - Nashed et al, Olanzapine Induced Weight Gain in Patients withBipolar I Disorder A Meta Analysis (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2047 Exhibit - Nashed et al, Olanzapine Induced Weight Gain in Patients withBipolar I Disorder A Meta Analysis (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2142 Exhibit - News Release Sunovion Pharmaceuticals Inc Announces FDAApproval of Latuda lurasidone HCl as Monotherapy andAdjunctive Therapy in Adult Patients with...
Cite Document
IPR2020-01053, No. 2142 Exhibit - News Release Sunovion Pharmaceuticals Inc Announces FDAApproval of Latuda lurasidone HCl as Monotherapy andAdjunctive Therapy in Adult Patients with Bipolar Depressio
+ More Snippets
Document
IPR2020-01053, No. 2071 Exhibit - O���Day et al, Long term cost effectiveness of atypical antipsychoticsin the treatment of adults with schizophrenia in the US (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2071 Exhibit - O���Day et al, Long term cost effectiveness of atypical antipsychoticsin the treatment of adults with schizophrenia in the US (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2066 Exhibit - Reiffen et al, Generic Drug Industry Dynamics (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2066 Exhibit - Reiffen et al, Generic Drug Industry Dynamics (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2140 Exhibit - M��ller, J Clin Psych (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2140 Exhibit - M��ller, J Clin Psych (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2052 Exhibit - Hoyberg et al, Risperidone versus perphenazine in the treatment ofchronic schizophrenic patients with acute exacerbations (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2052 Exhibit - Hoyberg et al, Risperidone versus perphenazine in the treatment ofchronic schizophrenic patients with acute exacerbations (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2084 Exhibit - Ng Mak et al, Patient Preferences for Important Attributes of BipolarDepression Treatments (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2084 Exhibit - Ng Mak et al, Patient Preferences for Important Attributes of BipolarDepression Treatments (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2045 Exhibit - Shayegan et al, Atypical Antipsychotics Matching Receptor Profile to Individual Patients Clinical Profile (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2045 Exhibit - Shayegan et al, Atypical Antipsychotics Matching Receptor Profile to Individual Patients Clinical Profile (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2044 Exhibit - Franklin, Lurasidone for the treatment of bipolar depression an evidence based review (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2044 Exhibit - Franklin, Lurasidone for the treatment of bipolar depression an evidence based review (P.T.A.B. Mar. 11, 2021)
+ More Snippets
Document
IPR2020-01053, No. 2054 Exhibit - Sachs et al, Efficacy and Safety of Adjunctive Oral Ziprasidone forAcute Treatment of Depression in Patients With Bipolar I Disorder (P.T.A.B. Mar. 11, 2021)
Cite Document
IPR2020-01053, No. 2054 Exhibit - Sachs et al, Efficacy and Safety of Adjunctive Oral Ziprasidone forAcute Treatment of Depression in Patients With Bipolar I Disorder (P.T.A.B. Mar. 11, 2021)
+ More Snippets